Title : Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.

Pub. Date : 2014 Jul

PMID : 24990105






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The M&T strategy costs US$20,730 per patient and yields a discounted QALY of 15.45, which represents incremental costs and health benefits of US$275 and 0.10 QALYs compared to current practice, and an ICER of US$2,996 per QALY gained. Adenosine Monophosphate cAMP responsive element modulator Homo sapiens